New drug can cut heart attack, stroke risk by 20%

Technology Oct 26, 2025

A major new study in The Lancet just found that semaglutide—a drug often used for weight loss and diabetes—can lower the risk of heart attacks and strokes by 20% in adults with a BMI of 27 or higher.
Over 17,000 people took part in the SELECT trial, showing real promise for those already dealing with heart issues.

Waistline reduction is key to heart benefits

Researchers noticed it's not just about losing weight overall—shrinking your waistline played a big role in these heart benefits, making up about a third of the effect.
Dr. Shreerang Godbole pointed out that semaglutide helps you feel full longer by mimicking your body's natural GLP-1 hormone signals, which can help with steady weight loss and better health.